These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 36902304)
1. Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages. Christodoulou CC; Papanicolaou EZ Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902304 [TBL] [Abstract][Full Text] [Related]
2. Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington's Disease Status Based on Omics Data. Christodoulou CC; Zachariou M; Tomazou M; Karatzas E; Demetriou CA; Zamba-Papanicolaou E; Spyrou GM Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049985 [TBL] [Abstract][Full Text] [Related]
3. Identification of molecular targets and small drug candidates for Huntington's disease via bioinformatics and a network-based screening approach. Hossain MR; Tareq MMI; Biswas P; Tauhida SJ; Bibi S; Zilani MNH; Albadrani GM; Al-Ghadi MQ; Abdel-Daim MM; Hasan MN J Cell Mol Med; 2024 Aug; 28(16):e18588. PubMed ID: 39153206 [TBL] [Abstract][Full Text] [Related]
4. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement. Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241 [TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed genes and regulatory relationships in Huntington's disease by bioinformatics analysis. Dong X; Cong S Mol Med Rep; 2018 Mar; 17(3):4317-4326. PubMed ID: 29328442 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatic gene analysis for potential therapeutic targets of Huntington's disease in pre-symptomatic and symptomatic stage. Xiang C; Cong S; Liang B; Cong S J Transl Med; 2020 Oct; 18(1):388. PubMed ID: 33054835 [TBL] [Abstract][Full Text] [Related]
7. Bioinformatic analysis of a microRNA regulatory network in Huntington's disease. Wang ZM; Dong XY; Cong SY J Integr Neurosci; 2020 Dec; 19(4):641-650. PubMed ID: 33378838 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis. Hoss AG; Kartha VK; Dong X; Latourelle JC; Dumitriu A; Hadzi TC; Macdonald ME; Gusella JF; Akbarian S; Chen JF; Weng Z; Myers RH PLoS Genet; 2014 Feb; 10(2):e1004188. PubMed ID: 24586208 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analysis of microRNA expression in Huntington's disease. Dong X; Cong S Mol Med Rep; 2018 Sep; 18(3):2857-2865. PubMed ID: 30015953 [TBL] [Abstract][Full Text] [Related]
10. Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases. Ge X; Yao T; Zhang C; Wang Q; Wang X; Xu LC Curr Alzheimer Res; 2022; 19(7):511-522. PubMed ID: 35929619 [TBL] [Abstract][Full Text] [Related]
11. miR-34a-5p as molecular hub of pathomechanisms in Huntington's disease. Hart M; Diener C; Lunkes L; Rheinheimer S; Krammes L; Keller A; Meese E Mol Med; 2023 Apr; 29(1):43. PubMed ID: 37013480 [TBL] [Abstract][Full Text] [Related]
12. Key Genes Associated with Pyroptosis in Gout and Construction of a miRNA-mRNA Regulatory Network. Bai B; Liu Y; Abudukerimu A; Tian T; Liang M; Li R; Sun Y Cells; 2022 Oct; 11(20):. PubMed ID: 36291136 [TBL] [Abstract][Full Text] [Related]
13. High-Throughput Sequencing of BACHD Mice Reveals Upregulation of Neuroprotective miRNAs at the Pre-Symptomatic Stage of Huntington's Disease. Olmo IG; Olmo RP; Gonçalves ANA; Pires RGW; Marques JT; Ribeiro FM ASN Neuro; 2021; 13():17590914211009857. PubMed ID: 33906482 [TBL] [Abstract][Full Text] [Related]
14. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis. Cheng Q; Chen X; Wu H; Du Y J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587 [TBL] [Abstract][Full Text] [Related]
16. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature. Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-9* in the peripheral leukocytes of Huntington's disease patients. Chang KH; Wu YR; Chen CM Orphanet J Rare Dis; 2017 Dec; 12(1):185. PubMed ID: 29258536 [TBL] [Abstract][Full Text] [Related]
18. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy. Dai Y; Guo M; Jiang L; Gao J Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030 [TBL] [Abstract][Full Text] [Related]
19. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis. Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322 [No Abstract] [Full Text] [Related]
20. TRAX Provides Neuroprotection for Huntington's Disease Via Modulating a Novel Subset of MicroRNAs. Weng YT; Chen HM; Chien T; Chiu FL; Kuo HC; Chern Y Mov Disord; 2022 Oct; 37(10):2008-2020. PubMed ID: 35997316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]